Similar to what we found regarding the most common protein features of AML patients, Ruvolo et al. showed that p-GSK3α/β, as an indicator of AKT activation, positively correlated with phosphorylation of AKT, BAD, and P70S6K [56]. This evidence concerns the gene GSK3A and acute myeloid leukemia.